EU Regulatory Reads, January 2018: Brexit And New Reg-Deadline Minefields
Executive Summary
2018 has had a bumpy start in the realm of EU regulations. The tangled Brexit issue has some in industry playing Russian roulette, while other deadlines are causing concerns. These issues and more were covered in the most popular Medtech Insight EU regulation stories from January.
You may also be interested in...
Revolutionary EU HTA Cooperation Proposal Will Use MDR/IVDR Platforms
The European Commission wants to rationalize health technology assessment work across the EU, and new EU medtech regulations offer an easy way to determine which products can benefit from joint clinical assessments.
Prepping For Brexit With Notified Body Switch Could Be Unnecessary Expense, BSI Warns
While there are some warnings that UK medical device companies should be jumping ship, and taking worst-case Brexit scenarios seriously, major notified body BSI believes there is too much scaremongering, and that a less disruptive EU-UK agreement is likely.
Deadline Confusion Raised Over EU's Up-Classified, Low-Risk Products
A recently published clarification on deadlines for meeting the EU new Medical Device Regulations leaves open one critical question: Can low-risk products being up-classified benefit from a compliance extension?